Compare HCA Health Inc (HCA) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Medtronic PLC — how do they compare? HCA Health Inc trades at $451.09 (market cap $96.35B), while Medtronic PLC trades at $88.48 (market cap $112.24B). The key difference: Medtronic PLC is the larger of the two by market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Medtronic PLC for 63 Days on average.
| HCA | MDT | |
|---|---|---|
Market Cap | $96.35B | $112.24B |
Volume | 1,079,453 | 105,663,236 |
Sector | Health | Health |
52-Week High | $545.13 | $105.35 |
52-Week Low | $361.32 | $73.75 |
Typical Hold Time | 76 Days | 63 Days |
Enterprise Value | $146.88B | $131.58B |
Dividend Yield | 0.7% | 3.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $445.01, up 1.33% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.60 billion in 2025, with net income of $6.78 billion, while valuation metrics like a P/E of 14.92 appear reasonable. The company announced a dividend of $0.78 and completed the acquisition of The College of Health Care Professions, signaling growth initiatives.
The outlook is positive, supported by analyst consensus with a $461.12 price target and 63% buy ratings, though risks include ongoing legal investigations and high debt levels. Earnings growth and operational efficiency remain key drivers for potential upside, but investors should monitor regulatory and competitive pressures.
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong analyst support (60.8% buy ratings) and a $97.80 consensus price target suggesting 11.5% upside. The stock shows consistent earnings beats in recent quarters and maintains a 49-year dividend growth streak. However, technical indicators signal bearish momentum with resistance near $89-90. Revenue growth accelerated to $33.54B in 2025 with net margins improving to 13.93%, though debt levels have risen to 31.1% of assets.
MDT presents a compelling value opportunity with attractive dividend yield and earnings momentum, but faces near-term technical headwinds and increasing leverage. The upcoming Q3 earnings report and MiniMed separation will be critical catalysts. Investors should weigh the strong fundamental recovery against bearish technical signals and monitor debt management closely.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
